InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
4
Disclosed sells
0
T+90 hit rate
39%
T+90 mean return
-6.6%
Across 18 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by WEISNER AIMEE S, Director. Insider active across 5 companies, notably GLAUKOS Corp. Aggregated, 28 reports have been logged. Breakdown: 4 buys · 0 sell. Total volume traded: €199k. History available since 3 June 2021. The latest transaction was filed on 8 August 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations28 total
25,000 shares@ US$32.0074.9% of flowCommon StockSEC:0001415889-24-021096:0
4,488 shares0Common StockSEC:0000950170-24-076863:0
1,716 shares0Common StockSEC:0001415889-24-015242:0
22,000 shares0Common StockSEC:0000950170-24-057101:0
1,750 shares@ US$38.1123.5% of flowCommon StockSEC:0000950170-24-031673:0
Ideal exit: 9 Dec 2024 (T+270)
895 shares0Common StockSEC:0001415889-24-000627:0
3,200 shares@ US$31.2134.9% of flowCommon StockSEC:0001209191-24-000222:0
497 shares@ US$40.187.3% of flowCommon StockSEC:0001209191-23-051752:0
2,000 shares@ US$48.7234.2% of flowCommon StockSEC:0000935836-23-000553:0
Ideal exit: 3 May 2024 (T+270)
3,417 shares0Common StockSEC:0001209191-23-038170:0
3,230 shares0Common StockSEC:0001415889-23-009285:0
9,288 shares0Common StockSEC:0000899243-23-014071:0
16,647 shares@ US$2.7585.1% of flowCommon StockSEC:0000899243-23-013731:0
Ideal exit: 16 Feb 2024 (T+270)
3,500 shares@ US$2.2914.9% of flowCommon StockSEC:0000899243-23-013424:0
Ideal exit: 11 Feb 2024 (T+270)
10,000 shares@ US$7.2757.1% of flowCommon StockSEC:0001415889-23-004666:0
33,191 sharesCommon StockSEC:0001209191-23-001101:0
1,572 shares0Common StockSEC:0001415889-23-000420:0
3,573 shares0Common StockSEC:0001209191-22-035063:0
4,364 shares0Common StockSEC:0001104659-22-068669:0
4,285 shares0Common StockSEC:0000899243-22-020017:0
1,455 shares0Common StockSEC:0001104659-22-001665
1,455 shares0Common StockSEC:0001104659-22-001665:0
2,000 shares@ US$51.660.0014% mcap50.0% of flowCommon StockSEC:0001104659-21-102397:0
2,000 shares@ US$51.669.0% of flowCommon StockSEC:0001104659-21-102397
3,466 shares0Common StockSEC:0001209191-21-039342:0
25 of 28 declarations
About WEISNER AIMEE S
Aimee S. Weisner serves as a board member at GLAUKOS Corp and Oyster Point Pharma, Inc. She plays a vital role in overseeing operations and making strategic decisions for these companies. Her expertise in biopharmaceuticals is crucial for ensuring the growth and sustainability of GLAUKOS and Oyster Point.
